Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1998-03-25
2004-12-07
Marschel, Ardin H. (Department: 1631)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S025300, C530S300000, C530S333000, C435S006120
Reexamination Certificate
active
06828427
ABSTRACT:
BACKGROUND OF THE INVENTION
Traditional processes of drug discovery involve the screening of complex fermentation broths and plant extracts for a desired biological activity or the chemical synthesis of many new compounds for evaluation as potential drugs. The advantage of screening mixtures from biological sources is that a large number of compounds are screened simultaneously, in some cases leading to the discovery of novel and complex natural products with activity that could not have been predicted otherwise. The disadvantages are that many different samples must be screened and numerous purifications must be carried out to identify the active component, often present only in trace amounts. On the other hand, laboratory syntheses give unambiguous products, but the preparation of each new structure requires significant amounts of resources. Generally, the de nova design of active compounds based on the high resolution structures of enzymes has not been successful.
It is thus now widely appreciated that combinatorial libraries are useful per se and that such libraries and compounds comprising them have great commercial importance. Indeed, a branch of chemistry has developed to exploit the many commercial aspects of combinatorial libraries.
In order to maximize the advantages of each classical approach, new strategies for combinatorial deconvolution have been developed independently by several groups. Selection techniques have been used with libraries of peptides (Geysen, H. M., Rodda, S. J., Mason, T. J., Tribbick, G. and Schoofs, P. G.,
J. Immun. Meth
. 1987, 102, 259-274; Houghten, R. A., Pinilla, C., Blondelle, S. E., Appel, J. R., Dooley, C. T. and Cuervo, J. H.,
Nature
, 1991, 354, 84-86; Owens, R. A., Gesellchen, P. D., Houchins, B. J. and DiMarchi, R. D.,
Biochem. Biophys. Res. Commun
., 1991, 181, 402-408; Doyle, M. V., PCT WO 94/28424; Brennan, T. M., PCT WO 94/27719); nucleic acids (Wyatt, J. R., et al.,
Proc. Natl. Acad. Sci. USA
, 1994, 91, 1356-1360; Ecker, D. J., Vickers, T. A., Hanecak, R., Driver, V. and Anderson, K.,
Nucleic Acids Res
., 1993, 21, 1853-1856); nonpeptides and small molecules (Simon, R. J., et al.,
Proc. Natl. Acad. Sci. USA
, 1992, 89, 9367-9371; Zuckermann, R. N., et al.,
J. Amer. Chem. Soc
., 1992, 114, 10646-10647; Bartlett, Santi, Simon, PCT W091/19735; Ohlmeyer, M. H., et al.,
Proc. Natl. Acad. Sci. USA
, 1993, 90, 10922-10926; DeWitt, S. H., Kiely, J. S., Stankovic, C. J., Schroeder, M. C. Reynolds Cody, D. M. and Pavia, M. R.,
Proc. Natl. Acad. Sci. USA
, 1993, 90, 6909-6913; Cody et al., U.S. Pat. No. 5,324,483; Houghten et al., PCT WO 94/26775; Ellman, U.S. Pat. No. 5,288,514; Still et al., PCT WO 94/08051; Kauffman et al., PCT WO 94/24314; Carell, T., Wintner, D. A., Bashir-Hashemi, A. and Rebek, J.,
Angew. Chem. Int. Ed. Engel
., 1994, 33, 2059-2061; Carell, T., Wintner, D. A. and Rebek, J.,
Angew. Chem. Int. Ed. Engel
., 1994, 33, 2061-2064; Lebl, et al., PCT WO 94/28028). A review of the above references reveals that the most advanced of these techniques are those for selection of peptides and nucleic acids. Several groups are working on selection of heterocycles such as benzodiazepines. With the exception of Rebek et al., scant attention has been given to combinatorial discovery of other types of molecules.
The majority of the techniques reported to date involve iterative synthesis and screening of increasingly simplified subsets of oligomers. Monomers or sub-monomers that have been utilized include amino acids, amino acid-like molecules, i.e. carbamate precursors, and nucleotides, both of which are bifunctional. Utilizing these techniques, libraries have been assayed for activity in either cell-based assays, or for binding and/or inhibition of purified protein targets.
A technique, called SURF™ (Synthetic Unrandomization of Randomized Fragments), involves the synthesis of subsets of oligomers containing a known residue at one fixed position and equimolar mixtures of residues at all other positions. For a library of oligomers four residues long containing three monomers (A, B, C), three subsets each containing 27 compounds would be synthesized (NNAN, NNBN, NNCN, where N represents equal incorporation of each of the three monomers). Each subset is then screened in a functional assay and the best subset is identified (e.g. NNAN). A second set of subsets is synthesized and screened, each containing the fixed residue from the previous round, and a second fixed residue (e.g. ANAN, BNAN, CNAN, each containing 9 molecules). Through successive rounds of screening and synthesis, a unique sequence with activity in the functional assay can be identified. The SURF™ technique is described in Ecker, D. J., Vickers, T. A., Hanecak, R., Driver, V. & Anderson, K.,
Nucleic Acids Res
., 1993, 21, 1853-1856. The SURF™ method is further described in PCT patent application WO 93/04204, the entire disclosure of which is herein incorporated by reference.
The combinatorial chemical approach that has been most utilized to date, utilizes an oligomerization from a solid support using monomeric units and a defined connecting chemistry, i.e. a solid support monomer approach. This approach has been utilized in the synthesis of libraries of peptides, peptoids, carbamates and vinylogous peptides connected by amide or carbamate linkages or nucleic acids connected by phosphate linkages as exemplified by the citations in previous paragraphs above. A mixture of oligomers (pool or library) is obtained from the addition of a mixture of activated monomers during the coupling step or from the coupling of individual monomers with a portion of the support (bead splitting) followed by remixing of the support and subsequent splitting for the next coupling. In this monomeric approach, each monomeric unit would carry a tethered letter, i.e., a functional group for interaction with the target. Further coupling chemistry that allows for the insertion of a tethered letter at a chemically activated intermediate stage is referred to as the sub-monomer approach.
The diversity of the oligomeric pool is represented by the inherent physical properties of each monomer, the number of different monomers mixed at each coupling, the physical properties of the chemical bonds arising from the coupling chemistry (the backbone), the number of couplings (length of oligomer), and the interactions of the backbone and monomer chemistries. Taken together, these interactions provide a unique conformation for each individual molecule.
There remains a need in the art for molecules which have fixed preorganized geometry that matches that of targets such as proteins and enzymes, nucleic acids, lipids and other targets. The backbone of such molecules should be rigid with some flexibility, and such molecules should be easy to construct via automated synthesis on solid support.
SUMMARY OF THE INVENTION
In accordance with this invention there are provided oligomeric compounds and libraries of such compounds comprising a plurality of aminodiol monomer subunits joined by linking groups, wherein each of said aminodiol monomer subunits has one of the structures I, II, III, IV, V, VI, VII, VIII, IX, X, or XI;
wherein:
each x is, independently, 0 to 5;
na, nb and nc are each, independently, 0 to 2, where the sum of na, nb and nc is from 1 to 5;
R
1
is —T—L or a base labile protecting group;
T is a single bond, a methylene group or a group having formula:
{[CR
6
R
7
]
m
—(R
5
)—[CR
8
R
9]
n
—[C(R
10
)]
p
—(E)—}
q
—
where:
R
10
is ═O, ═S, or ═NR
11
;
R
5
and E, independently, are a single bond, CH═CH, C∇C, O, S, NR
11
, or C
6
-C
14
aryl;
each R
6
, R
7
, R
8
, R
9
, R
11
, R
12
and R
13
are, independently, H, alkyl or haloalkyl having 1 to about 10 carbon atoms, alkenyl having 2 to about 10 carbon atoms, alkynyl having 2 to about 10 carbon atoms, or aryl having 7 to about 14 carbon atoms;
m and n, independently, are 0 to 5;
p is 0 or 1;
q is 1 to about 10;
L is H, substituted or unsubstituted C
2
-C
10
alkyl, substituted or uns
ISIS Pharmaceuticals Inc.
Marschel Ardin H.
Woodcock & Washburn LLP
LandOfFree
Oligomeric aminodiol-containing compounds, libraries... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligomeric aminodiol-containing compounds, libraries..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligomeric aminodiol-containing compounds, libraries... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3293731